课题基金 / 基金详情

Analysis of the intracellular regulatory mechanism of bcl-2 related apoptosis.

Analysis of the intracellular regulatory mechanism of bcl-2 related apoptosis.
bcl-2相关细胞凋亡的细胞内调控机制分析
批准号:
07670238
负责人:
TANAKA Shigeki
金额:
$1.28万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1996

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
1. Anti-apoptotic effect and the expression of p26 bcl-2 We have investigated the anti-apoptotic effect of bcl-2 proto-oncogene using bcl-2 transfectants (bcl-2 was introduced to CCRF-CEM,MBC-1, WEHI-164,2AD4) with various factor inducible apoptosis. The cells expressing a large amount of p26 bcl-2 showed higher viability when cell death was induced with H_2O_2, Dexamethasone and anti-lgM.Especially, bcl-2 has a stronger anti-apoptotic effect in the death induced with H_2O_2 than in the death induced with others. There was no significant correlation between the anti-apoptotic effect and the expression of p26 bcl-2 in the cell death induced with A23187, TNF-alpha. 2. Intarcellular events in the early phase of apoptosis and the expression of p26 bcl-2 The studies of intracellular reactive oxygen species and mitochondrial transmembrane potential of MBC-1 cells using fluorescence dye revealed no significant difference between bcl-2 transfectants and controls when cell death was induced with H_2O_2. Whereas p26 bcl-2 has significant anti-apoptotic effect in MBC-1 cells undergoing apoptosis with H_2O_2. When the transfectants of CEM-C7 cells were treated with H_2O_2, reactive oxygen species were markedly reduced but not correlate with the level of p26 bcl-2. Both intracellular reactive oxygen species and mitochondrial transmembrane potential showed no significant change in CEM,MBC-1 cells when cell death was induced with dexamethasone and anti-lgM respectively. These results suggest the anti-apoptotic effect of p26 bcl-2 has some direct relation to reactive oxygen species in early phase of apoptosis.
期刊论文(18)
专著(0)
科研奖励(0)
会议论文
Yoshihiro Komada: "Fas Receptor (CD95)-mediated apoptosis is induced in leukemic cells entering G1B compartment of the cell cycle." Blood. 86. 3848-3860 (1995)
Yoshihiro Komada:“Fas 受体 (CD95) 介导的细胞凋亡在进入细胞周期 G1B 区室的白血病细胞中被诱导。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Shinichi Kitada: "Reversal of chemoresistance of lymphoma cell by antisense-mediated reduction of bcl-2 gene expression" Antisense Research and Developmment. 4. 71-79 (1994)
Shinichi Kitada:“通过反义介导的 bcl-2 基因表达减少来逆转淋巴瘤细胞的化疗耐药性”反义研究与开发。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Shinichi Kitada: "Reversal of chemoresistance of lymphoma cells by antisense-mediatedreduction of bcl-2 gene expression." Antisense Research and Devlopment. 4. 71-79 (1994)
Shinichi Kitada:“通过反义介导的 bcl-2 基因表达减少来逆转淋巴瘤细胞的化疗耐药性。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yoshihiro Komada et al.: "Fas Receptor (CD95) -mediated cytotoxicity is responsible for the apoptotic cell death of leukemic cells induced by interleukin-2-activated T cells." British Journal of Haematology. 96. 147-157 (1997)
Yoshihiro Komada 等人:“Fas 受体 (CD95) 介导的细胞毒性是白细胞介素 2 激活的 T 细胞诱导白血病细胞凋亡的原因。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
18
    国内基金
    海外基金
    Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
    • 批准号:
      LBY21H010001
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2020
    • 负责人:
      郑绪阳
    • 依托单位:
    基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
    • 批准号:
      81703335
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2017
    • 负责人:
      卫高菲
    • 依托单位:
    双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
    • 批准号:
      81670594
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2016
    • 负责人:
      陈昊
    • 依托单位:
    Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
    • 批准号:
      81470791
    • 项目类别:
      面上项目
    • 资助金额:
      73.0万元
    • 批准年份:
      2014
    • 负责人:
      董家鸿
    • 依托单位: